Cleared Traditional

K053498 - HYPEROX 101

K053498 is an FDA 510(k) clearance for HYPEROX 101, manufactured by Wjo, Inc.. The device is a Class 2 Anesthesiology device with product code CBF cleared through the Traditional 510(k) pathway after a 89-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 2006
Decision
89d
Days
Class 2
Risk

K053498 is an FDA 510(k) clearance for the HYPEROX 101. Classified as Chamber, Hyperbaric (product code CBF), Class II - Special Controls.

Submitted by Wjo, Inc. (Bristol, US). The FDA issued a Cleared decision on March 15, 2006 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5470 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K053498

510(k) Number K053498 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 16, 2005
Decision Date March 15, 2006
Days to Decision 89 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 140d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CBF Device Classification - Class 2, Special Controls

Product Code CBF Chamber, Hyperbaric
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5470
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBF Chamber, Hyperbaric

All 56
Devices cleared under the same product code (CBF) and FDA review panel - the closest regulatory comparables to K053498.
SIGMA SERIES HYPERBARIC CHAMBER
K072427 · Perry Baromedical Corp. · Jun 2008
DIVE AND SHALLOW AND GRAND DIVE
K072757 · Summit TO Sea · Feb 2008
MONOPLACE HYPERBARIC OXYGEN TREATMENT SYSTEM, MODEL BLKS-307
K060739 · Khrunichev State Research & Production Space Centr · Jul 2006
OXYHEAL 1000 MONOPLACE HYPERBARIC CHAMBER
K052866 · Oxyheal Health Group · Dec 2005
FLEXI-LITE, MODEL FL-V1.2
K051759 · Performance Hyperbarics · Nov 2005
MODEL 3300E/ER MONOPLACE HYPERBARIC OXYGEN CHAMBER
K052713 · Sechrist Industries, Inc. · Oct 2005